Protein is a Promising Candidate for Prognostic Marker, Drug Target, Researchers Say | GenomeWeb

A receptor protein involved in embryonic development and wound repair appears to encourage the progression of colorectal cancer, and may prove useful as a prognostic marker and as a drug target, according Richard Bates of the department of Pathology at the Beth Israel Deaconess Medical Center in Boston, who led a Harvard team’s investigation of the protein.

The team’s study of the protein — called ß6 — appeared in the Jan. 20 online version of The Journal of Clinical Investigation, and will be published in the Feb. 1 issue of the journal.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.